Physician profile
Amiel Moshfegh
NPI 1144539644
$201,880.06
in general payments reported to CMS, 2019-2025
13 companies · $82K in 2025
The $82K reported for 2025 was more than what 98% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,865 · 2020: $1,027 · 2021: $1,972 · 2022: $1,437 · 2023: $32K · 2024: $82K · 2025: $82K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $194K · Food and Beverage: $1,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $194,250.01 |
| Food and Beverage | $1,328.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $194,812.12 | 2022-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $4,279.74 | 2019-2024 | Perclose Prostyle, Diamondback Peripheral, Diamondback Coronary |
| Philips North America LLC | $1,228.17 | 2019-2024 | (Br5) Peripheral Ivus |
| Medtronic, INC. | $478.00 | 2021-2025 | Turbohawk, Silverhawk |
| Medtronic Vascular, INC. | $343.76 | 2019-2020 | |
| Boston Scientific Corporation | $223.22 | 2019-2024 | Avvigo Guidance System, Opticross 35, Coyote Es |
| Veryan Medical Incorporated | $166.35 | 2023 | Biomimics 3d Vascular Stent System |
| Dova Pharmaceuticals | $122.60 | 2019 | |
| Bard Peripheral Vascular, INC. | $86.76 | 2023-2024 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm |
| Becton, Dickinson and Company | $68.35 | 2023-2024 | Lifestream, Lifestent Solo Vascular Stent, Rotarexs 6 F X 135 Cm |
| Vyne Pharmaceuticals INC. | $26.49 | 2021 | |
| Cardiovascular Systems INC. | $24.02 | 2023 | Diamondback Peripheral |
| Nevro Corp. | $20.48 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amiel Moshfegh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.